| Lynx1 Capital Management Lp |
Non-Executive |
Cullinan Therapeutics, Inc. (CGEM)
|
2025-10-28 |
$8.40 |
0.0% |
165,667
|
$1,391,686 |
| Lynx1 Capital Management Lp |
Non-Executive |
Neuphoria Therapeutics Inc. (NEUP)
|
2025-10-21 |
$5.14 |
0.0% |
639,110
|
$3,283,108 |
| Lynx1 Capital Management Lp |
Non-Executive |
Cullinan Therapeutics, Inc. (CGEM)
|
2025-10-17 |
$8.46 |
0.0% |
248,749
|
$2,103,912 |
| Lynx1 Capital Management Lp |
Non-Executive |
Cullinan Therapeutics, Inc. (CGEM)
|
2025-10-10 |
$6.73 |
0.0% |
1,459,641
|
$9,826,941 |
| Lynx1 Capital Management Lp |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2025-09-15 |
$6.99 |
0.0% |
32,008
|
$223,735 |
| Lynx1 Capital Management Lp |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2025-07-24 |
$5.70 |
0.0% |
128,848
|
$733,826 |
| Lynx1 Capital Management Lp |
Non-Executive |
TScan Therapeutics, Inc. (TCRX)
|
2025-05-20 |
$1.20 |
0.0% |
2,588,794
|
$3,106,553 |
| Lynx1 Capital Management Lp |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2024-12-27 |
$12.90 |
-95.0% |
18,682
|
$241,038 |
| Lynx1 Capital Management Lp |
Non-Executive |
TScan Therapeutics, Inc. (TCRX)
|
2024-12-13 |
$2.93 |
0.0% |
131,800
|
$385,769 |
| Lynx1 Capital Management Lp |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2024-11-27 |
$12.47 |
-95.0% |
22,818
|
$284,520 |
| Lynx1 Capital Management Lp |
Non-Executive |
TScan Therapeutics, Inc. (TCRX)
|
2024-11-15 |
$4.34 |
0.0% |
947
|
$4,114 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-2.3% |
$-499,280 |
$21,585,201 |